Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Altair Therapeutics
company
About
Altair Therapeutics was a biopharmaceutical company that focused on developing therapeutics to treat human respiratory diseases.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $17M
- Industries
- Biopharma,Biotechnology,Therapeutics
- Founded date
- Jan 1, 2007
- Number Of Employee
- 1 - 10
- Operating Status
- Close
Altair Therapeutics is a biopharmaceutical company focused on developing therapeutics to treat human respiratory diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$17M
Altair Therapeutics has raised a total of
$17M
in funding over 2 rounds. Their latest funding was raised on
Feb 2, 2010 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 2, 2010 | Series B | $17M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Altair Therapeutics is funded by 1 investors.
AgeChem Venture Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
AgeChem Venture Fund
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
